Get notified when JAGX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsJaguar Health converts 7.92 preferred shares to 64,668 common shares in two Streeterville deals
Filed June 2, 2026 · Period ending June 1, 2026 · ~1 min read
Key Changes
-
medium
Company exchanged 7.92 shares of Series Q Preferred Stock for 64,668 common shares with Streeterville in two transactions (May 26 and June 1), diluting existing common shareholders while simplifying capital structure.
Item 3.02 verify on EDGAR → -
medium
Exchanges leave approximately 400 of the original 408 Series Q Preferred shares issued to Streeterville on May 19 still outstanding, suggesting potential for additional conversions.
Item 3.02 verify on EDGAR → -
low
Common shares issued under Section 3(a)(9) exemption without SEC registration, a standard exemption for exchanges with existing security holders.
Item 3.02 verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.
Partner
Trade JAGX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify